Few Transgender Patients get Fertility Preservation Treatments Prior to Transition
Oct 31, 2017
Origin: ASRM Press Release
HIGHLIGHTS FROM THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE’S 2017 SCIENTIFIC CONGRESS & EXPO
Note: Press room open Sun. October 29, 2pm-5pm CDT; Mon. October 30-Wed. November 1, 8:00am-5:30pm CDT. 210-582-7029
San Antonio, TX- In studies presented at the American Society for Reproductive Medicine’s Scientific Congress it was revealed that very few transgender patients receive the full set of medical treatments they might benefit from. Specifically, most do not obtain fertility preservation treatments prior to transitioning or use contraception which may still be needed.
The first study surveyed over 30 transgendered patients from a university affiliated OB GYN clinic who had undergone gender transition (23 transmen and 9 transwomen). Patients were asked about reproductive history, contraceptive use and desire for fertility preservation. None of the transmen had undergone egg retrieval and freezing for fertility preservation. Ten reported that economics drove that decision. Only one patient reported a desire to carry a pregnancy in the future. A majority of the transwomen (56%) and a significant number (30%) of the transmen reported believing that the hormones they were on acted as a contraceptive. None of the patients reported an unplanned pregnancy either before or after their transition.
Researchers at Washington University in St Louis reviewed medical records of 67 adolescent patients with gender dysphoria. There were 22 male to female (MtF) patients and 45 female to male (FtM). The patients had received various forms of pubertal suppression and cross sex hormone treatments. Only 22 of the 67 had documentation of their reproductive wishes. Two MtF patients had undergone gamete preservation, none of the FtM patients had.
“It is important that transgender patients know that fertility preservation is an option for them. This research seems to indicate that we need to do a better job in educating the wider public and fellow physicians on the wider availability and clinical application of fertility preservation treatments,” said Christos Coutifaris MD, PhD, President-Elect of the ASRM.
P-21 L. Abern et al,” CONTRACEPTIVE USE AND FERTILITY PRESERVATION AMONG TRANSGENDER INDIVIDUALS: ARE WE DOING ENOUGH?”
P-22 A. P. Schelble et al,” FERTILITY PRESERVATION (FP) REFERRAL AND FOLLOW-UP IN MALE-TO-FEMALE (MTF) AND FEMALE-TO-MALE (FTM) TRANSGENDER PATIENTS.”
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers. The Society is committed to facilitating and sponsoring educational activities for the lay public and continuing medical education activities for professionals who are engaged in the practice of and research in reproductive medicine. www.asrm.org